Breathe Well-being, a startup that reverses diabetes has raised Rs 50 crore in a pre-series B investment that was jointly led by 3One4 Capital, Accel, and General Catalyst. Supermorpheus and FounderBank Capital also took part in the round.
In order to improve the client experience, the business will use the cash to strengthen its coaching academy, grow its core workforce, and scale up its technological platform, as per reported by BW Disrupt.
Rohan Verma, Co-founder and CEO, Breathe Well-being says, “Our aim is a Diabetes Mukt Bharat (Diabetes Free India) with the aim to reverse diabetes for 1 Million Indians by 2025 and we are well on track to achieve that goal.”
The Gurgaon-based health-tech startup was founded in 2020 by Rohan Verma (ex-McKinsey) and Aditya Kaicker (ex-Accenture).
Radhika Ananth, Vice President, Accel, “We have been impressed by how quickly Breathe Well-being is becoming a household name for Type 2 Diabetes and Pre-Diabetes Reversal across Tier 2 and 3 cities of India. I realised the true value of what Rohan and Aditya are building at Breathe Well-being after seeing my own mother go through the program and reduce her HbA1c levels significantly. Hence Accel invested and we continue to back them in their vision of building a Diabetes Mukt Bharat.”
The team firmly believes that medication is not a long-term solution to diabetes and instead focuses on behavioral and lifestyle changes to reverse diabetes and reduce the risk of chronic lifestyle diseases.
The company claims itself to be India’s No. 1 clinically proven diabetes reversal company, helping people lower their HbA1c and blood sugar levels through lifestyle changes.
About Breathe Well-being
By making lifestyle changes, Breathe Well-being, India’s No. 1 clinically proven diabetes reversal firm, helps patients lower their HbA1c and blood glucose levels. It’s the capacity to combine the power of technology with human empathy to produce a measurable change in the lives of its consumers.